{"id":"https://openalex.org/W2019829775","doi":"https://doi.org/10.1124/mol.108.050807","title":"90-kDa Heat Shock Protein Inhibition Abrogates the Topoisomerase I Poison-Induced G2/M Checkpoint in p53-Null Tumor Cells by Depleting Chk1 and Wee1","display_name":"90-kDa Heat Shock Protein Inhibition Abrogates the Topoisomerase I Poison-Induced G2/M Checkpoint in p53-Null Tumor Cells by Depleting Chk1 and Wee1","publication_year":2008,"publication_date":"2008-09-27","ids":{"openalex":"https://openalex.org/W2019829775","doi":"https://doi.org/10.1124/mol.108.050807","mag":"2019829775","pmid":"https://pubmed.ncbi.nlm.nih.gov/18820127","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2685054"},"language":"en","primary_location":{"id":"doi:10.1124/mol.108.050807","doi":"https://doi.org/10.1124/mol.108.050807","is_oa":true,"landing_page_url":"https://doi.org/10.1124/mol.108.050807","pdf_url":"https://molpharm.aspetjournals.org/content/molpharm/75/1/124.full.pdf","source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://molpharm.aspetjournals.org/content/molpharm/75/1/124.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114045976","display_name":"Archie N. Tse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Archie N. Tse","raw_affiliation_strings":["Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. tsea@mskcc.org","Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. tsea@mskcc.org","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041344060","display_name":"Tahir N. Sheikh","orcid":"https://orcid.org/0000-0002-9410-1712","observed_orcids":["https://orcid.org/0000-0002-9410-1712"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tahir N. Sheikh","raw_affiliation_strings":["Laboratory of New Drug Development , Division of Solid Tumor Oncology , Department of Medicine (A.N..) , and Molecular Pharmacology and Chemistry Program (T.C.C.) , Memorial Sloan Kettering Cancer Center , New York , New York","Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine (A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of New Drug Development , Division of Solid Tumor Oncology , Department of Medicine (A.N..) , and Molecular Pharmacology and Chemistry Program (T.C.C.) , Memorial Sloan Kettering Cancer Center , New York , New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine (A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036572642","display_name":"Alan Loh Ho","orcid":"https://orcid.org/0000-0002-6885-3742","observed_orcids":["https://orcid.org/0000-0002-6885-3742"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ho Alan","raw_affiliation_strings":["Laboratory of New Drug Development , Division of Solid Tumor Oncology , Department of Medicine (A.N..) , and Molecular Pharmacology and Chemistry Program (T.C.C.) , Memorial Sloan Kettering Cancer Center , New York , New York","Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine (A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of New Drug Development , Division of Solid Tumor Oncology , Department of Medicine (A.N..) , and Molecular Pharmacology and Chemistry Program (T.C.C.) , Memorial Sloan Kettering Cancer Center , New York , New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine (A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026225196","display_name":"Ting\u2010Chao Chou","orcid":"https://orcid.org/0000-0002-3340-1594","observed_orcids":["https://orcid.org/0000-0002-3340-1594"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ting-Chao Chou","raw_affiliation_strings":["Laboratory of New Drug Development , Division of Solid Tumor Oncology , Department of Medicine (A.N..) , and Molecular Pharmacology and Chemistry Program (T.C.C.) , Memorial Sloan Kettering Cancer Center , New York , New York","Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine (A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of New Drug Development , Division of Solid Tumor Oncology , Department of Medicine (A.N..) , and Molecular Pharmacology and Chemistry Program (T.C.C.) , Memorial Sloan Kettering Cancer Center , New York , New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine (A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":["Laboratory of New Drug Development , Division of Solid Tumor Oncology , Department of Medicine (A.N..) , and Molecular Pharmacology and Chemistry Program (T.C.C.) , Memorial Sloan Kettering Cancer Center , New York , New York","Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine (A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of New Drug Development , Division of Solid Tumor Oncology , Department of Medicine (A.N..) , and Molecular Pharmacology and Chemistry Program (T.C.C.) , Memorial Sloan Kettering Cancer Center , New York , New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine (A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":2.0262,"has_fulltext":true,"cited_by_count":43,"citation_normalized_percentile":{"value":0.85957008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"75","issue":"1","first_page":"124","last_page":"133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hsp90-inhibition","display_name":"HSP90 inhibition","score":0.8830000162124634},{"id":"https://openalex.org/keywords/17-allylamino-17-demethoxygeldanamycin","display_name":"17-allylamino-17-demethoxygeldanamycin","score":0.9670000076293945},{"id":"https://openalex.org/keywords/g2-m-checkpoint","display_name":"G2/M checkpoint","score":0.8939999938011169},{"id":"https://openalex.org/keywords/topoisomerase-i-poisons","display_name":"topoisomerase I poisons","score":0.8259999752044678},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.9520000219345093},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.8349999785423279},{"id":"https://openalex.org/keywords/p53-null-cells","display_name":"p53-null cells","score":0.9179999828338623},{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.968999981880188},{"id":"https://openalex.org/keywords/wee1","display_name":"WEE1","score":0.9390000104904175},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.7419999837875366},{"id":"https://openalex.org/keywords/hsp90-client-proteins","display_name":"Hsp90 client proteins","score":0.8220000267028809},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.5849999785423279},{"id":"https://openalex.org/keywords/hct116-cells","display_name":"HCT116 cells","score":0.8830000162124634},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5370000004768372},{"id":"https://openalex.org/keywords/proteasome-inhibition","display_name":"proteasome inhibition","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C2781252693","wikidata":"https://www.wikidata.org/wiki/Q7979264","display_name":"Wee1","level":5,"score":0.8785000443458557},{"id":"https://openalex.org/C2777560012","wikidata":"https://www.wikidata.org/wiki/Q5924361","display_name":"Hsp90 inhibitor","level":5,"score":0.595260500907898},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4938064515590668},{"id":"https://openalex.org/C205260736","wikidata":"https://www.wikidata.org/wiki/Q418939","display_name":"Heat shock protein","level":3,"score":0.48142120242118835},{"id":"https://openalex.org/C2775932338","wikidata":"https://www.wikidata.org/wiki/Q24772687","display_name":"Hsp90","level":4,"score":0.43890824913978577},{"id":"https://openalex.org/C54086632","wikidata":"https://www.wikidata.org/wiki/Q5512671","display_name":"G2-M DNA damage checkpoint","level":5,"score":0.4264652729034424},{"id":"https://openalex.org/C186000732","wikidata":"https://www.wikidata.org/wiki/Q6881914","display_name":"Mitotic catastrophe","level":4,"score":0.42572999000549316},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4172726273536682},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.41677069664001465},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.403541624546051},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.3879951238632202},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3817288279533386},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3707256317138672},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.3302832245826721},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3131588101387024},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.22872918844223022},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17751231789588928},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06539711356163025}],"mesh":[{"descriptor_ui":"D000071877","descriptor_name":"Checkpoint Kinase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004264","descriptor_name":"DNA Topoisomerases, Type I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004264","descriptor_name":"DNA Topoisomerases, Type I","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016195","descriptor_name":"G2 Phase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016227","descriptor_name":"Benzoquinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D045325","descriptor_name":"HCT116 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047029","descriptor_name":"Lactams, Macrocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1124/mol.108.050807","doi":"https://doi.org/10.1124/mol.108.050807","is_oa":true,"landing_page_url":"https://doi.org/10.1124/mol.108.050807","pdf_url":"https://molpharm.aspetjournals.org/content/molpharm/75/1/124.full.pdf","source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2685054","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2685054","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Pharmacol","raw_type":"Text"},{"id":"pmid:18820127","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18820127","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1124/mol.108.050807","doi":"https://doi.org/10.1124/mol.108.050807","is_oa":true,"landing_page_url":"https://doi.org/10.1124/mol.108.050807","pdf_url":"https://molpharm.aspetjournals.org/content/molpharm/75/1/124.full.pdf","source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2019829775.pdf","grobid_xml":"https://content.openalex.org/works/W2019829775.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W23429827","https://openalex.org/W1496226640","https://openalex.org/W1509643601","https://openalex.org/W1524628399","https://openalex.org/W1654430325","https://openalex.org/W1722100967","https://openalex.org/W1837329986","https://openalex.org/W1959988533","https://openalex.org/W1966373529","https://openalex.org/W1966516622","https://openalex.org/W1967880683","https://openalex.org/W1971727708","https://openalex.org/W1979397363","https://openalex.org/W1996505651","https://openalex.org/W2007305884","https://openalex.org/W2012677683","https://openalex.org/W2013996808","https://openalex.org/W2021534705","https://openalex.org/W2037811560","https://openalex.org/W2038143768","https://openalex.org/W2040196552","https://openalex.org/W2042740031","https://openalex.org/W2046691565","https://openalex.org/W2049531015","https://openalex.org/W2049877855","https://openalex.org/W2065644280","https://openalex.org/W2067693418","https://openalex.org/W2073685453","https://openalex.org/W2075707444","https://openalex.org/W2076324577","https://openalex.org/W2078142614","https://openalex.org/W2080125477","https://openalex.org/W2097173890","https://openalex.org/W2097555718","https://openalex.org/W2101103624","https://openalex.org/W2103562758","https://openalex.org/W2104903083","https://openalex.org/W2105768236","https://openalex.org/W2113684644","https://openalex.org/W2114647652","https://openalex.org/W2119237325","https://openalex.org/W2126942327","https://openalex.org/W2131833681","https://openalex.org/W2136277289","https://openalex.org/W2141927027","https://openalex.org/W2143404342","https://openalex.org/W2145339037","https://openalex.org/W2149938795","https://openalex.org/W2154141161","https://openalex.org/W2171806736","https://openalex.org/W6600918156","https://openalex.org/W6629685804","https://openalex.org/W6637078336","https://openalex.org/W6638983679","https://openalex.org/W6640720713","https://openalex.org/W6675329087","https://openalex.org/W6681530865"],"related_works":["https://openalex.org/W2278086980","https://openalex.org/W2067693418","https://openalex.org/W1979397363","https://openalex.org/W2106788103","https://openalex.org/W1966373529","https://openalex.org/W2168464626","https://openalex.org/W2045436471","https://openalex.org/W2094757427","https://openalex.org/W4291676920","https://openalex.org/W1974657451"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}